Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Seagen Inc.
Genmab
Eli Lilly and Company
Qilu Pharmaceutical Co., Ltd.
AstraZeneca
AstraZeneca
Eli Lilly and Company
Eli Lilly and Company
M.D. Anderson Cancer Center
Deciphera Pharmaceuticals, LLC
Eli Lilly and Company
Emory University
Canadian Cancer Trials Group
AstraZeneca
Celgene
Daiichi Sankyo
Oncology Institute of Southern Switzerland
Dana-Farber Cancer Institute
AbbVie
Amgen
Sanofi
University of California, San Francisco